Delivery Order SPE2DX22D0049-SPE2D826FA2AH
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $10,750.82 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. AmerisourceBergen, a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $903,311.36 to AmerisourceBergen Drug Corp on November 15, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The delivery order is being performed...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $25,740.22 to AmerisourceBergen Drug Corp on December 8, 2025, with completion expected by December 9, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,637.83 to AmerisourceBergen Drug Corp on December 6, 2025, with completion expected by December 8, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract is non-set-aside and competitively awarded,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,343.79 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $14,731.84 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award (Contract No. 4568975942) represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The contract will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $110,265.05 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order represents a non-competitive award leveraging AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $24,324.86 to AmerisourceBergen Drug Corp on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract and serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,575.92 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price, competitively awarded delivery order was issued under a non-set-aside procurement to the pharmaceutical distributor's Corporate Office division, based in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA2AHDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,257.39 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement requirements for military and veteran healthcare systems through its federal contract portfolio. As a prime vendor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's consistent success in competitively awarded delivery orders demonstrates its capability to meet federal medical supply requirements while serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 11/30/25 |